First European implantation of KONAR-MF occluder Percutaneous ventricular septal defect (VSD) closure remains a complex intervention 1 . In the patient population requiring this intervention, small, flexible and low-profile devices may offer good closure rates with a low rate of complications 1,2 . Previously, off-label use of patent ductus arteriosus (PDA) devices (e.g., AMPLATZER™ PDA devices [ADO I and II; St. Jude Medical, St. Paul, MN, USA]) has been reported in several case series [1] [2] [3] . In May 2018, the KONAR-MF™ multifunctional VSD device (Lifetech, Shenzhen, China) received CE-mark approval for VSD closure after first-inman implantation in 2013. The KONAR-MF VSD device is made from 144-wire nitinol mesh, is designed as a hybrid between singledisc and double-disc PDA devices, with/without PTFE membrane and can be used through a 4-7 Fr sheath or guiding catheter with a 1.15-1.8-inch inner lumen. It can be screwed at both sides and therefore its placement can be from the left ventricle (LV) or right ventricle (RV), which means retrograde or antegrade.
We describe the first series of European implantations after CE approval in May 2018. Patients with clinical indication for perimembranous VSD closure and who had haemodynamically relevant but restrictive VSDs were selected for an interventional approach. All patients were assessed by transthoracic echocardiography (TTE), electrocardiogram (ECG) and Holter ECG and clinical status between November 2017 and April 2018. All interventions were performed between May and July 2018 under conscious sedation (midazolam and propofol) and local anaesthesia, using a standardised protocol. The aneurysmatic VSDs were passed with a right 4 or 5 Fr modified Amplatz catheter (Cordis Medical, Cashel, Ireland) and an arteriovenous loop was established for passage of the 5-7 Fr implantation sheath (Lifetech). All interventions were guided by transthoracic or transoesophageal echocardiography.
Device implantation was successful in four patients, who had VSDs ranging in size from 2 to 6.5 mm. The following devices were used: 10/8, 9/7, 10/8 and 14/12 mm. In two patients, devices were upsized during the procedure according to significant residual shunting (Figure 1, Moving image 1, Moving image 2) . All patients treated underwent standardised follow-up examinations with demonstration of effective function without significant residual shunting or arrhythmia. This is the first report of successful VSD closure in paediatric and adult patients with the new and CE-marked KONAR-MF VSD device. It has a favourable low profile for antegrade and retrograde implantation; however, more data are needed before possible device-related long-term complications can be ruled out.
